GO:0051938 L-glutamate import: Neuronal Signaling and Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051938 L-glutamate import describes the directed movement of L-glutamate into a cell or organelle, a process essential for neurotransmitter recycling and metabolic homeostasis [1,6].
• Key transporters include SLC1A2 (EAAT2) and SLC1A3 (EAAT1) in glia, and SLC7A11 (xCT) for cystine/glutamate exchange, which together regulate extracellular glutamate levels.
• Dysregulated L-glutamate import is implicated in brain diseases such as Alzheimer's disease, and in cancer metabolic reprogramming, including breast cancer brain metastasis [4,5].
• In pancreatic tumors, glutamate metabolism supports the tumor microenvironment, highlighting the role of L-glutamate import in cancer progression.
• Engineered microbes such as Klebsiella pasteurii can be optimized for L-glutamate production by modulating importers/exporters, demonstrating biotechnological relevance.
• Astrocytic L-glutamate import influences oxidative stress and lipid droplet formation, linking this process to cellular stress responses.
Description
L-glutamate import (GO:0051938) is a biological process defined as the directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle. This process is fundamental for maintaining glutamate homeostasis, as glutamate serves dual roles as an excitatory neurotransmitter and a key metabolic intermediate [1,6]. In the central nervous system, efficient import of glutamate into glial cells prevents excitotoxicity and supports neurotransmitter recycling. Beyond the brain, L-glutamate import is critical in peripheral tissues, where it contributes to metabolic reprogramming in conditions such as cancer and fibrosis [2,5,8]. Understanding the molecular players and regulatory mechanisms of L-glutamate import is therefore essential for researchers studying neurobiology, oncology, and metabolic disorders.
L-glutamate import At A Glance
| GO ID | GO:0051938 |
|---|---|
| GO term | L-glutamate import |
| Ontology | biological_process |
| Synonym | L-glutamate uptake |
| Major function | Transport of L-glutamate into cells or organelles |
| Related transporters | SLC1A2, SLC1A3, SLC7A11 |
| Associated diseases | Alzheimer's disease, breast cancer brain metastasis, pulmonary fibrosis |
| Research methods | CRISPR knockout, overexpression, metabolic assays, imaging |
What Is GO:0051938?
According to the Gene Ontology, GO:0051938 L-glutamate import is the directed movement of L-glutamate, the L-enantiomer of the anion of 2-aminopentanedioic acid, into a cell or organelle. This process encompasses the transport of glutamate across cellular membranes, mediated by specific transporters, and is distinct from glutamate biosynthesis or catabolism. It is a biological process that ensures proper glutamate levels for signaling and metabolism [1,6].
Why Is L-glutamate import Important in Cell Biology?
L-glutamate import is crucial for normal physiology because it regulates extracellular glutamate concentrations, preventing excitotoxicity and supporting metabolic pathways. In the brain, glial glutamate transporters such as EAAT1/2 (SLC1A3/SLC1A2) are responsible for the majority of glutamate uptake, and their dysfunction is linked to neurodegenerative diseases. In cancer, glutamate import supports tumor growth and metabolic adaptation, as seen in breast cancer brain tropism and pancreatic tumors [2,5]. Additionally, in pulmonary fibrosis, glutamate metabolism intersects with TGF-β signaling to drive myofibroblast differentiation. Thus, studying L-glutamate import provides insights into diverse pathological conditions and potential therapeutic targets.
• Prevents excitotoxicity by clearing excess glutamate from the synaptic cleft.
• Supports neurotransmitter recycling in glia and neurons.
• Contributes to metabolic reprogramming in cancer cells, including breast cancer brain metastasis.
• Plays a role in pancreatic tumor microenvironment metabolism.
• Linked to oxidative stress regulation in astrocytes.
• Involved in TGF-β-driven myofibroblast differentiation in pulmonary fibrosis.
• Relevant for biotechnological production of L-glutamate in engineered microbes.
• Potential target for Alzheimer's disease therapy.
• Modulates lipid droplet formation in astrocytes.
• Key for understanding glutamate homeostasis in health and disease [1,6].
What Happens During L-glutamate import?
Recognition and Binding of L-glutamate
In simple terms: The transporter first grabs glutamate from outside the cell.
L-glutamate import begins with the recognition of extracellular L-glutamate by specific membrane transporters. These transporters, such as the excitatory amino acid transporters (EAATs), bind glutamate with high affinity. This binding is the first step in the directed movement of glutamate into the cell.
Transport Across the Membrane
In simple terms: The transporter moves glutamate through the cell membrane.
Following binding, the transporter undergoes conformational changes to translocate L-glutamate across the lipid bilayer. This process is often coupled to the co-transport of sodium ions, utilizing the electrochemical gradient. In glial cells, EAAT1 and EAAT2 mediate the bulk of glutamate uptake, which is essential for terminating synaptic transmission.
Intracellular Release and Metabolic Fate
In simple terms: Once inside, glutamate is used or converted.
After import, L-glutamate is released into the cytoplasm, where it can be converted to glutamine by glutamine synthetase or enter metabolic pathways. In astrocytes, imported glutamate can influence oxidative stress and lipid droplet formation, as shown in recent studies. This intracellular handling ensures that glutamate is not only cleared but also recycled for further signaling.
Regulation of Transporter Activity
In simple terms: The process is controlled by various signals.
The activity of glutamate transporters is regulated at multiple levels, including gene expression, post-translational modifications, and interaction with other proteins. For instance, in brain diseases, the expression of System x(c)-/xCT/SLC7A11 and EAAT1/2 is altered, affecting glutamate import. Additionally, metabolic signals such as TGF-β can coordinate alanine synthesis and import, indirectly influencing glutamate metabolism.
Key Genes Involved in GO:0051938 L-glutamate import
The following genes encode transporters and related proteins that directly mediate or regulate L-glutamate import, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC1A2 (EAAT2) | Primary glial glutamate transporter | Major regulator of extracellular glutamate; linked to neurodegeneration |
| SLC1A3 (EAAT1) | Glial glutamate transporter | Involved in glutamate clearance; associated with brain diseases |
| SLC7A11 (xCT) | Cystine/glutamate exchanger | Modulates glutamate import and oxidative stress; implicated in brain diseases |
| SLC1A1 (EAAT3) | Neuronal glutamate transporter | Contributes to glutamate uptake in neurons; potential role in excitotoxicity |
| SLC1A6 (EAAT4) | Glutamate transporter in Purkinje cells | Regulates glutamate signaling in cerebellum |
| SLC1A7 (EAAT5) | Retinal glutamate transporter | Involved in visual processing |
| GLS | Glutaminase | Converts glutamine to glutamate, influencing import needs |
| GLUL | Glutamine synthetase | Metabolizes imported glutamate in astrocytes |
| SLC38A1 | Glutamine transporter | Indirectly affects glutamate import by supplying glutamine |
| SLC38A2 | Glutamine transporter | Supports glutamate metabolism in cancer |
| SLC7A5 | L-type amino acid transporter | May influence glutamate import through amino acid exchange |
| SLC3A2 | Chaperone for SLC7A11 | Essential for xCT function in glutamate import |
| ATF3 | Transcription factor | Regulates genes involved in glutamate metabolism under stress |
| SIRT6 | Deacetylase | Modulates ATF3 activity, potentially affecting glutamate import |
| TGF-β | Cytokine | Coordinates alanine synthesis and import, impacting glutamate metabolism |
| NF-κB | Transcription factor | Regulates cytokine secretion and glutamate metabolic reprogramming |
How Is L-glutamate import Regulated?
L-glutamate import is regulated at transcriptional, post-transcriptional, and post-translational levels. In brain diseases, altered expression of glutamate transporters such as EAAT1/2 and xCT is observed, affecting import capacity. The transcription factor ATF3, whose nuclear import is enhanced by SIRT6-mediated deacetylation, can regulate genes involved in glutamate metabolism, linking cellular stress to glutamate import. Additionally, TGF-β signaling coordinates alanine synthesis and import, which may indirectly influence glutamate homeostasis. In cancer, NF-κB-mediated cytokine secretion converges with glutamate metabolic reprogramming, suggesting inflammatory signals modulate glutamate import.
L-glutamate import and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC1A2 | Alzheimer's disease, excitotoxicity | Knockout mice, neuronal cultures |
| SLC7A11 | Brain diseases, oxidative stress | CRISPR knockout in astrocytes |
| NF-κB | Breast cancer brain metastasis | Xenograft models, knockout cell lines |
| TGF-β | Pulmonary fibrosis | Knockout mice, fibroblast cultures |
| SIRT6 | Lung fibrosis | Knockout mice, epithelial cells |
L-glutamate import in Neurodegeneration
Dysfunctional glutamate import is a hallmark of several neurodegenerative conditions. In Alzheimer's disease, impaired glutamate uptake by glial transporters leads to excitotoxicity and neuronal loss. Glial glutamate transporter-mediated plasticity involving System x(c)-/xCT/SLC7A11 and EAAT1/2 is altered in brain diseases, contributing to pathology. These findings highlight the importance of maintaining efficient glutamate import for neuronal health.
L-glutamate import in Cancer Metabolism
Cancer cells often reprogram glutamate metabolism to support growth. In breast cancer brain tropism, NF-κB-mediated cytokine secretion and glutamate metabolic reprogramming converge to promote metastasis. In pancreatic tumors, the metabolic landscape reveals altered glutamate pathways, including import, which support the tumor microenvironment. Targeting glutamate import may therefore offer therapeutic opportunities in oncology.
L-glutamate import in Fibrosis
Pulmonary fibrosis involves metabolic changes, including glutamate metabolism. TGF-β coordinates alanine synthesis and import for myofibroblast differentiation, a key process in fibrosis. Additionally, silica-induced lung fibrosis involves SIRT6-mediated deacetylation of ATF3, which enhances its nuclear import and may affect glutamate-related gene expression. These studies suggest that glutamate import contributes to fibrotic remodeling.
From L-glutamate import-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC1A2 knockout affect glutamate clearance? | SLC1A2 knockout mice or CRISPR KO cells |
| Can point mutation in SLC7A11 alter transport activity? | CRISPR point mutation knock-in cells |
| What is the effect of SLC1A3 overexpression on glutamate import? | Overexpression cell lines |
| How does tagged EAAT2 localize in astrocytes? | Tagged knock-in mice or cells |
| Does NF-κB regulate glutamate metabolic genes? | NF-κB knockout cancer cells |
| Is TGF-β required for alanine import in fibrosis? | TGF-β receptor knockout fibroblasts |
How to Study the L-glutamate import Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Rate of glutamate import | Quantifying transporter activity in vitro |
| Fluorescent glutamate sensors | Real-time intracellular glutamate levels | Live-cell imaging in neurons and glia |
| CRISPR knockout | Loss-of-function effects on glutamate import | Identifying essential transporters |
| Overexpression | Gain-of-function effects | Testing sufficiency of a transporter |
| RNA-seq | Transcriptional changes in glutamate transporters | Profiling disease models |
| Proteomics | Protein expression and modifications | Identifying regulatory pathways |
| Metabolic flux analysis | Glutamate utilization pathways | Cancer metabolism studies |
Metabolic Assays for Glutamate Import
Glutamate import can be measured using radiolabeled glutamate uptake assays or fluorescent glutamate sensors. These methods quantify the rate of import in live cells and have been used to study astrocytic glutamate handling.
Genetic Knockout and Overexpression Studies
CRISPR/Cas9-mediated knockout or overexpression of transporters such as SLC1A2 and SLC7A11 allows researchers to dissect their specific roles in glutamate import. Such approaches have revealed the contribution of these transporters to brain diseases and cancer [5,6].
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can identify changes in glutamate transporter expression under various conditions. For example, metabolic landscape studies in pancreatic tumors have highlighted altered glutamate pathways.
Imaging Glutamate Dynamics
Genetically encoded glutamate sensors and two-photon microscopy enable real-time visualization of glutamate import in tissue slices. This approach has been used to study glial glutamate transporter plasticity.
How CRISPR Can Be Used to Study GO:0051938 L-glutamate import
Knockout
CRISPR knockout of genes such as SLC1A2 or SLC7A11 can abolish glutamate import, revealing their necessity in cellular processes. For example, knockout of SLC7A11 in astrocytes alters oxidative stress responses.
Point Mutation
Introducing point mutations in transporter genes can mimic human polymorphisms or disrupt key residues, allowing structure-function studies of glutamate import. This approach is valuable for understanding disease-associated variants.
Knock-in
Knock-in of tagged transporters (e.g., GFP-EAAT2) enables visualization and tracking of glutamate import dynamics in live cells. Such models have been used to study transporter localization.
Overexpression
Overexpression of glutamate transporters can enhance import capacity and protect against excitotoxicity. This strategy is used to test therapeutic potential in neurodegeneration models.
How EDITGENE Supports L-glutamate import Research
Researchers studying L-glutamate import-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for L-glutamate import research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SLC1A3 Knockout HEK293 Cell Line | EDJ-KQ2547 | Human | 6507 | Details Get a Quote |
| SLC17A8 Knockout HEK293 Cell Line | EDJ-KQ3835 | Human | 246213 | Details Get a Quote |
| SLC1A1 Knockout HEK293 Cell Line | EDJ-KQ5760 | Human | 6505 | Details Get a Quote |
| SLC17A6 Knockout HEK293 Cell Line | EDJ-KQ15300 | Human | 57084 | Details Get a Quote |
| SLC1A1 Knockout A-549 Cell Line | EDJ-KQ29174 | Human | 6505 | Details Get a Quote |
| SLC1A1 Knockout HCT 116 Cell Line | EDJ-KQ29175 | Human | 6505 | Details Get a Quote |
| SLC1A1 Knockout HeLa Cell Line | EDJ-KQ29176 | Human | 6505 | Details Get a Quote |
| SLC1A3 Knockout HCT 116 Cell Line | EDJ-KQ24577 | Human | 6507 | Details Get a Quote |
| SLC1A3 Knockout HeLa Cell Line | EDJ-KQ24578 | Human | 6507 | Details Get a Quote |
| SLC17A6 Knockout HeLa Cell Line | EDJ-KQ56795 | Human | 57084 | Details Get a Quote |
| SLC17A8 Knockout HeLa Cell Line | EDJ-KQ59229 | Human | 246213 | Details Get a Quote |
| SLC1A3 Knockout A-549 Cell Line | EDJ-KQ62965 | Human | 6507 | Details Get a Quote |
| SLC17A6 Knockout A-549 Cell Line | EDJ-KQ65301 | Human | 57084 | Details Get a Quote |
| SLC17A8 Knockout A-549 Cell Line | EDJ-KQ67697 | Human | 246213 | Details Get a Quote |
| SLC17A6 Knockout HCT 116 Cell Line | EDJ-KQ73742 | Human | 57084 | Details Get a Quote |
Displaying Records 1 To 15 Of 16 Records
Frequently Asked Questions About L-glutamate import
What is L-glutamate import?
L-glutamate import (GO:0051938) is the directed movement of L-glutamate into a cell or organelle, mediated by specific transporters [1,6].
What genes are involved in L-glutamate import?
Key genes include SLC1A2, SLC1A3, SLC7A11, and others encoding glutamate transporters.
How is L-glutamate import regulated?
It is regulated by transcriptional, post-translational mechanisms, and signaling pathways such as TGF-β and NF-κB [5,7,8].
Why is L-glutamate import important in the brain?
It prevents excitotoxicity and supports neurotransmitter recycling, and its dysfunction is linked to neurodegeneration [4,6].
What diseases are associated with L-glutamate import?
Alzheimer's disease, breast cancer brain metastasis, and pulmonary fibrosis are among the conditions linked to altered glutamate import [4,5,8].
How can I study L-glutamate import in the lab?
Methods include radiolabeled uptake assays, fluorescent sensors, CRISPR knockout, and overexpression models [1,5,6].
What are the main transporters for L-glutamate import?
EAAT1 (SLC1A3) and EAAT2 (SLC1A2) are major glial transporters, while xCT (SLC7A11) mediates cystine/glutamate exchange.
Can L-glutamate import be targeted for cancer therapy?
Yes, targeting glutamate import may disrupt tumor metabolism, as seen in breast cancer brain metastasis and pancreatic tumors [2,5].
What is the role of SLC7A11 in L-glutamate import?
SLC7A11 (xCT) imports cystine while exporting glutamate, influencing oxidative stress and glutamate homeostasis.
How does EDITGENE support L-glutamate import research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, and screening services for genes involved in L-glutamate import.
Conclusion
L-glutamate import (GO:0051938) is a fundamental biological process that maintains glutamate homeostasis and supports diverse physiological functions. Its dysregulation is implicated in neurodegeneration, cancer, and fibrosis, making it a compelling target for research and therapeutic development. By leveraging CRISPR-based models and advanced methodologies, researchers can unravel the complex regulation of glutamate import and identify new intervention points.
References
- 1. Rubio-Atonal LF et al.. 2025. Glutamate decreases oxidative stress and lipid droplet formation in astrocytes.. J Cell Sci 138(19) PMID: 40958651
- 2. Bonilla ME et al.. 2024. Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment.. JCI Insight 9(18) PMID: 39315547
- 3. Yoshimura R et al.. 2026. l-Glutamate exporters/importers responsible for diazotrophic l-glutamate production in engineered Klebsiellapasteurii.. J Biosci Bioeng 142(4):342-348 PMID: 42557147
- 4. Huang 黄振羽 Z et al.. 2025. A Model for the Development of Alzheimer's Disease.. Genomics Proteomics Bioinformatics 23(6) PMID: 40985690
- 5. Di Russo S et al.. 2025. NF-κB-mediated cytokine secretion and glutamate metabolic reprogramming converge in breast cancer brain tropism.. Cancer Lett 630:217907 PMID: 40639610
- 6. Dahlmanns M et al.. 2023. Glial Glutamate Transporter-Mediated Plasticity: System x(c)(-)/xCT/SLC7A11 and EAAT1/2 in Brain Diseases.. Front Biosci (Landmark Ed) 28(3):57 PMID: 37005761
- 7. Cheng D et al.. 2026. SIRT6-Mediated Deacetylation of ATF3 Promotes Silica-Induced Lung Fibrosis by Enhancing its Nuclear Import via Binding to Importin α.. Adv Sci (Weinh) 13(46):e75782 PMID: 42160006
- 8. Li F et al.. 2026. TGF-β coordinates alanine synthesis and import for myofibroblast differentiation in pulmonary fibrosis.. JCI Insight 11(13) PMID: 42024472
